Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical DevelopmentBiomolecules · 2026-07-02Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic Circuits.Human Brain Mapping · 2026-06-30Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical DevelopmentUniversity of Groningen research database (University of Groningen / Centre for Information Technology) · 2026-06-28Psilocybin-Assisted Therapy for Physician Well-Being and Burnout: Feasibility, Safety, Clinical Effectiveness and Biomarkers of Response [PAT-B (Psilocybin-Assisted Therapy for Physician Well-Being and Burnout)]ClinicalTrials.gov · 2026-06-25Divergent changes in perturbation-induced brain reconfiguration following depression treatment with psilocybin and escitaloprambioRxiv · 2026-06-25Distinct brain responses to psilocybin and escitalopram in depression captured by the Fluctuation-Dissipation TheorembioRxiv · 2026-06-15Efficacy of Psilocybin-Assisted Therapy in Major Depressive Disorder: A Systematic Review and Meta-AnalysisPsychiatry International · 2026-06-14Prenatal stress, excitatory-inhibitory imbalance, and ADHD risk: a hypothesis-driven perspective on psilocybin-induced neuroplasticityTranslational Psychiatry · 2026-06-04Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in ratsCell Reports Medicine · 2026-05-31Psilocybin-induced neurocardiogenic syncope: a case reportPsychopharmacology · 2026-05-27Psilocybin-Assisted Therapy in Depressive Disorders: Efficacy, Safety, and Persistence of Clinical Effects - A Narrative ReviewJournal of Education Health and Sport · 2026-05-06Psilocybin use among Basotho healers and non-healers in southern AfricaUnknown journal · 2026-04-22Psilocybin use in Puerto Rico: Patterns, motivations, and personality correlates from an online surveyJournal of Psychedelic Studies · 2026-04-14A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experienceFrontiers in Public Health · 2026-04-13Sex-specific increased reactivity of the PVT and prolonged PVT→CeA circuit engagement following psilocin administrationNature Communications · 2026-04-09Additional file 1 of Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depressionFigshare · 2026-04-08Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depressionBMC Medical Education · 2026-04-07A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depressionNature Mental Health · 2026-04-05An Open-Label Study of Single-Dose Psilocybin for Borderline Personality Disorder With Co-Occurring Major Depressive DisorderClinical Neuropharmacology · 2026-03-31Age moderates the relationship between psychedelics use and mental health in naturalistic settingsResearch Square · 2026-03-09Behavioural investigations of psilocybin in non-human animals 1962-2021: A scoping reviewJournal of Psychedelic Studies · 2026-03-08Psilocybin-assisted psychotherapy for psycho-existential distress in advanced cancer: a narrative reviewBMJ Supportive & Palliative Care · 2026-02-17Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care - PATH StudyClinicalTrials.gov · 2026-02-16Placebo Effects in the Treatment of Depression-Implications for the Psychedelic Renaissance.Neurologic clinics · 2026-01-31MDMA and Psilocybin Regulate Oligodendrocyte-Lineage Cell Numbers and Anxiety-Like Behaviors in a Rat Model of FearBiological Psychiatry · 2026-01-31PSILOCYBIN IN PSYCHIATRIC PRACTICE AND PSYCHEDELIC-ASSISTED THERAPY FOR TREATMENT-RESISTANT DEPRESSIONInternational Journal of Innovative Technologies in Social Science · 2026-01-27Methodological moderators of psilocybin-assisted therapy in depression: A systematic review and meta-analysisNeuroscience & Biobehavioral Reviews · 2026-01-23Insights into psilocybin use among people with bipolar disorder: A thematic analysis of Reddit postsJournal of Affective Disorders · 2026-01-19Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Symptoms of Anxiety and Depression: Safety and Efficacy Outcomes of a Phase 1/2 StudyPsychedelic Medicine · 2026-01-17Bridging the reporting gap: Application of the ReSPCT guidelines in psilocybin clinical trial protocolsEuropean Neuropsychopharmacology · 2026-01-15Behavioral and Neural Mechanisms Supporting Psilocybin-assisted Therapy for Phantom Limb PainClinicalTrials.gov · 2026-01-08Daily Administration of Psilocin Mucate (L-130) Produces a Favorable Safety Profile and Anxiolytic Effects in Rodents Exposed to Chronic Unpredictable Mild StressJournal of Psychoactive Drugs · 2026-01-01The effects of psilocybin on psychological distress in cancer patients: a systematic review and meta-analysisBMC Psychology · 2026-01-01Preclinical evaluation of psilocybin as an anti-inflammatory agentNeuroscience Applied · 2025-12-31Psilocybin as a Serotonergic Therapy in Epilepsy: Narrative Review of Therapeutic Potentials and Seizure RisksUnknown journal · 2025-12-28Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 StudyPsychedelic Medicine · 2025-12-22Feasibility Phase 2 Study of Psilocybin-Assisted Therapy for Opioid-Refractory Pain in Patients With Advanced CancerClinicalTrials.gov · 2025-12-15Psilocybin-assisted psychotherapy for treatment-resistant obsessive-compulsive disorder: protocol for an open-label pilot studyBJPsych Open · 2025-12-14COMPARATIVE EFFICACY AND ACCEPTABILITY OF PSILOCYBIN-KETAMINE AND TYPICAL ANTIDEPRESSANTS FOR MAJOR DEPRESSIVE DISORDER MANAGEMENT: A NETWORK META-ANALYSISUnknown journal · 2025-12-10Are Magic Mushrooms the Magic to Healing?DigitalCommons - Kennesaw State University (Kennesaw State University) · 2025-12-07Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Disorders: A Scoping ReviewPsychedelic Medicine · 2025-11-23Advancing treatment paradigms: the role of psilocybin in managing major depressive disorderAnnals of Medicine and Surgery · 2025-11-23Sex-specific role of the 5-HT2A receptor in psilocybin-induced extinction of opioid rewardNature Communications · 2025-11-19Novel qNMR Methodto Quantify Psilocybin and Psilocinin Psychedelic MushroomsFigshare · 2025-11-09Novel qNMR Method to Quantify Psilocybin and Psilocin in Psychedelic MushroomsACS Omega · 2025-11-09The Psychedelic Psilocin Suppresses Activity of Central Amygdala Corticotropin-Releasing Factor Receptor 1 Neurons and Decreases Ethanol Drinking in Female MiceJournal of Neuroscience · 2025-11-09Psilocybin mitigates chronic behavioral and neurobiological alterations in a rat model of recurrent intimate partner violence-related brain injuryMolecular Psychiatry · 2025-11-04Psilocybin-assisted therapy for demoralisation in hospice patients: feasibility, safety and preliminary efficacyBMJ Supportive & Palliative Care · 2025-11-02Psychedelic-induced behavioral and developmental effects on zebrafish: a systematic review.Unknown journal · 2025-10-19Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review.Unknown journal · 2025-10-15Daily self-assessment within a regimen of microdosing indicates enhanced psychological functioning on microdosing days relative to non-microdosing days.Psychopharmacology · 2025-10-10Set and setting in psilocybin-assisted therapy: A qualitative study of patients with cancer and depressionGeneral Hospital Psychiatry · 2025-10-10Psilocybin during the postpartum period induces long-lasting adverse effects in both mothers and offspringNature Communications · 2025-09-29High dose of psilocybin induces acute behavioral changes without inducing conditioned place preference in Sprague-Dawley ratsJournal of Psychopharmacology · 2025-09-21Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.Unknown journal · 2025-09-06Biochemical Insights into Diverse Psilocybe Mushrooms and Their Metabolites as Sources of Neuroactive Agents: A ReviewUnknown journal · 2025-08-31Psilocybin with psychotherapeutic support for treatment-resistant depression: a pilot clinical trialTherapeutic Advances in Psychopharmacology · 2025-08-31Unsupervised Extractive Summarization of Psychedelic User Experience ReportsmedRxiv · 2025-08-26“To Have the Encounter with Our Own Finiteness in that Existential Way”: Descriptions of Existential Experience in Patients with Cancer and Major Depression Participating in Psilocybin-Assisted Group TherapyPsychedelic Medicine · 2025-08-24Psychedelics and Headache Disorders: an Update.Current neurology and neuroscience reports · 2025-08-08Substance Abuse and Cognitive Decline: The Critical Role of Tau Protein as a Potential Biomarker.Unknown journal · 2025-08-06Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreatFrontiers in Psychiatry · 2025-08-05Therapeutic and legal aspects of psilocybin in cancer-related depressionFrontiers in Psychiatry · 2025-08-03Mapping psilocybin therapy: A systematic review of therapeutic frameworks, adaptations, and standardization across contemporary clinical trials.Unknown journal · 2025-07-17Exploring the Frontiers of Psychedelics: A New Chromatographic Method for Detection and Quantification of Psilocybin and Psilocin in Psilocybe cubensis MushroomsACS Omega · 2025-07-09Evaluation of behavioural and neurochemical effects of psilocybin in mice subjected to chronic unpredictable mild stressTranslational Psychiatry · 2025-06-13Comparison of the Effects of PEX20 (Oral Psilocin), PEX30 (Sublingual Psilocin), and PEX10 (Oral Psilocybin) in Healthy AdultsClinicalTrials.gov · 2025-06-09Role of endogenous serotonin in psychedelic-like effects of psilocybin in miceThe International Journal of Neuropsychopharmacology · 2025-05-24The effect of psychedelic microdosing on animal behavior: A review with recommendations for the field.Unknown journal · 2025-05-08Psilocybin Mitigates Behavioral Despair and Cognitive Impairment in Treatment-resistant Depression Model using Wistar Kyoto RatsResearch Square · 2025-05-05Psilocybin-assisted psychotherapy as a rapid-acting treatment for cancer-related depression and anxiety: Evidence from a network meta-analysisThe International Journal of Psychiatry in Medicine · 2025-04-24Patterns of Internalizing Problems, Substance Use and Cognitive Flexibility Before and After Naturalistic Psilocybin Use: A Repeated Measures Latent Profile AnalysisInternational Journal of Mental Health and Addiction · 2025-04-23Psilocybin and ketamine affect novel neuropeptides gene expression in the rat hypothalamusJournal of Psychopharmacology · 2025-04-16Regulatory Alignment of Psilocybin Clinical Trials in Major Depressive Disorder on ClinicalTrials.gov: A Cross-Sectional AnalysisPharmacopsychiatry · 2025-04-16Psilocin alleviates acute itch in mice: possible involvement of 5-HT2A receptors and kynurenine pathwayNaunyn-Schmiedeberg s Archives of Pharmacology · 2025-04-14Psilocybin’s lasting action requires pyramidal cell types and 5-HT2A receptorsNature · 2025-04-01Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavementBMJ Open · 2025-03-31LPS-Induced Liver Inflammation Is Inhibited by Psilocybin and Eugenol in MicePharmaceuticals · 2025-03-22Therapeutic Potential of Psilocybin for Treating Neuropsychiatric Long COVID Symptoms: A Reddit InvestigationJournal of Psychoactive Drugs · 2025-03-13BIOLOGICAL ACTIVITY OF PSILOCYBIN EXTRACTS FROM THE FRUITING BODIES OF PSILOCYBE CUBENSIS ANTIOXIDANT AND ANTIMICROBIAL POTENTIALJournal of Microbiology Biotechnology and Food Sciences · 2025-03-12Psilocybin for disorders of consciousness: A case-report studyClinical Neurophysiology · 2025-03-07Risks of using psilocybin in treatment of treatment-resistant depressionJournal of Education Health and Sport · 2025-03-05Psilocin, A Psychedelic Drug, Exerts Anticonvulsant Effects Against PTZ- and MES-Induced Seizures in Mice via 5-HT1A and CB1 Receptors: Involvement of Nitrergic, Opioidergic, and Kynurenine PathwaysPharmacology Research & Perspectives · 2025-02-24Latent Class Analysis of Changes in Substance Use and Depressive Symptoms following Naturalistic Psilocybin Use: Results from a Prospective Longitudinal SurveyDrug and Alcohol Dependence · 2025-01-31Uncovering Psychedelics: From Neural Circuits to Therapeutic Applications.Unknown journal · 2025-01-18Self-reported experiences and perspectives on using psychedelics to manage opioid use among participants of two Reddit communities.Addiction (Abingdon, England) · 2025-01-15Clinical and preclinical evidence of psilocybin as antidepressant. A narrative review.Unknown journal · 2025-01-05Perturbing whole-brain models of brain hierarchy: an application for depression following pharmacological treatmentbioRxiv · 2025-01-01Early psilocybin intervention alleviates behavioral despair and cognitive impairment in stressed Wistar ratsProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2024-12-31Home-based psilocybin-assisted therapy for a patient with advanced cancer: A case reportPalliative & Supportive Care · 2024-12-31Brain dynamics of classical psychedelics show paradoxical hierarchical flattening with increased complexitybioRxiv · 2024-12-21Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 PandemicJAMA Network Open · 2024-12-04Narrative review of psilocybin, an important psychoactive substance with potential peri-anesthetic implicationsTrends in Anaesthesia and Critical Care · 2024-11-30Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. healthcare professionalsScientific Reports · 2024-11-13Long-term effects of psilocybin on dynamic and effectivity connectivity of fronto-striatal-thalamic circuitsbioRxiv · 2024-11-06Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: An open-label, pilot clinical trialPsyArXiv · 2024-11-03Optimized psilocybin production in tryptophan catabolism-repressed fungiMicrobial Biotechnology · 2024-10-31“The mushroom was more alive and vibrant”: Patient reports of synthetic versus organic forms of psilocybinJournal of Psychedelic Studies · 2024-10-28Increased reactivity of the paraventricular nucleus of the hypothalamus and decreased threat responding in male rats following psilocin administrationUNC Libraries · 2024-10-21Examining differences in the effects and contexts of naturalistic psilocybin use for White participants vs. Participants of Color: A longitudinal online survey studyJournal of Affective Disorders · 2024-10-21Plain Language Summary Publication: Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: Results from an open-label phase Ib ascending dose studyHeadache The Journal of Head and Face Pain · 2024-10-08Exploring the biocatalysis of psilocybin and other tryptamines: Enzymatic pathways, synthetic strategies, and industrial implications.Unknown journal · 2024-10-03The Action on Psilocybin in Neural Plasticity, Brain Reorganization and Cognitive EnhancementMiddle East Research Journal of Biological Sciences · 2024-09-27An Open-Label Pilot Study Examining the Feasibility, Safety, and Effectiveness of Psilocybin Therapy for Depression in Bipolar II DisorderClinicalTrials.gov · 2024-09-24Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: results from an open-label phase Ib ascending dose studyHeadache The Journal of Head and Face Pain · 2024-09-19Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.Unknown journal · 2024-09-11Psilocybin-Assisted Therapy for Brain Cancer Related Existential Distress: A Case-ReportJournal of Palliative Medicine · 2024-09-11Mind over matter: the microbial mindscapes of psychedelics and the gut-brain axis.Pharmacological research · 2024-08-31A Cohort Based Case Series: Learnings from an Iterative Group Therapy Model to Support Psilocybin-Assisted Therapy for Patients with a Terminal DiagnosisUnknown journal · 2024-08-26Improving Access to Psilocybin-Assisted Therapy: Barriers, Challenges, and RecommendationsUnknown journal · 2024-08-26A virtual clinical trial of psychedelics to treat patients with disorders of consciousnessbioRxiv · 2024-08-18Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depressionNature Mental Health · 2024-08-04Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges.Unknown journal · 2024-07-19Acute Psychedelic Effects and Clinical Outcomes are Associated With Therapeutic Alliance Among Participants Receiving Psilocybin TherapyDrug and Alcohol Dependence · 2024-06-30Associations Between Harm Reduction Strategy Use and Acute Psychedelic Effects in Spanish Speakers who Used LSD or PsilocybinDrug and Alcohol Dependence · 2024-06-30Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorderFrontiers in Psychiatry · 2024-06-10A scoping review of the effects of mushroom and fungus extracts in rodent models of depression and tests of antidepressant activity.Unknown journal · 2024-06-02Pharmacological and behavioural effects of tryptamines present in psilocybin-containing mushroomsBritish Journal of Pharmacology · 2024-06-01Psychedelic therapy in depression and substance use disorders.Unknown journal · 2024-05-20The influence of psilocybin on subconscious and conscious emotional learningiScience · 2024-05-18Psilocybin as a new way for depression treatmentJournal of Education Health and Sport · 2024-05-14Evolving Guidelines for the Use of Touch During a Clinical Trial of Group Psilocybin-Assisted TherapyPsychedelic Medicine · 2024-05-07Problems of Qualification of Trafficking in Plants and Plant Parts Containing Psychoactive Substances and Mushrooms Containing Psilocybin and (or) PsilocinDrug control · 2024-03-13The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorderPLoS ONE · 2024-03-13Psychedelic Therapy: A Primer for Primary Care Clinicians-PsilocybinAmerican Journal of Therapeutics · 2024-02-29Strong Bipartisan Support for Controlled Psilocybin Use as Treatment or Enhancement in a Representative Sample of US Americans: Need for Caution in Public Policy PersistsAJOB Neuroscience · 2024-02-04Older adults in psychedelic-assisted therapy trials: A systematic review.Unknown journal · 2024-01-18Evaluation of the long-term cognitive effects of psilocybin in a chronic stress mouse modelNeuroscience Applied · 2023-12-31Psychedelic Therapy: A Primer for Primary Care Clinicians - Part I. Historical Perspective and OverviewPsyArXiv · 2023-12-25Psychedelic Therapy: A Primer for Primary Care Clinicians - Part IV. PsilocybinPsyArXiv · 2023-12-25Determination of psilocybin and psilocin content in multiple Psilocybe cubensis mushroom strains using liquid chromatography - tandem mass spectrometryAnalytica Chimica Acta · 2023-12-17Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysisCancer · 2023-12-17Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorderCancer · 2023-12-17Psilocybin in Bipolar II Study Provides Preliminary Data on SafetyJAMA Psychiatry · 2023-12-05Psychedelic renaissance: Revitalized potential therapies for psychiatric disorders.Unknown journal · 2023-11-01Pharmacological and behavioral effects of tryptamines present in psilocybin-containing mushroomsbioRxiv · 2023-10-22Therapeutic Potential of Psilocybin for Treating Psychological Distress among Survivors of Adverse Childhood Experiences: Evidence on Acceptability and Potential Efficacy of Psilocybin UseJournal of Psychoactive Drugs · 2023-10-09UNRAVELLING THE ROLE OF5-HT2AR ACTIVATION IN THE LONG-LASTING BEHAVIORAL EFFECTS OF PSILOCYBINIBRO Neuroscience Reports · 2023-09-30PSILOCYBIN EXERTS ANTIDEPRESSANT EFFECTS IN A CHRONIC UNPREDICTABLE MILD STRESS (CUMS) ANIMAL MODELIBRO Neuroscience Reports · 2023-09-30Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal surveyFrontiers in Psychiatry · 2023-09-18The zebrafish for preclinical psilocybin research.Unknown journal · 2023-09-06Applying Key Lessons from the Hospice and Palliative Care Movement to Inform Psychedelic-Assisted Therapy.Psychedelic medicine (New Rochelle, N.Y.) · 2023-08-31Single-Dose Psilocybin Treatment for Major Depressive DisorderJAMA · 2023-08-30Three Cases of Reported Improvement in Microsmia and Anosmia Following Naturalistic Use of Psilocybin and LSDJournal of Psychoactive Drugs · 2023-08-30Development and validation of a sensitive LC-MS-MS method to quantify psilocin in authentic oral fluid samplesJournal of Analytical Toxicology · 2023-08-27Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders.Unknown journal · 2023-08-23Developing a Direct Observation Measure of Therapeutic Connection in Psilocybin-Assisted Therapy: A Feasibility StudyJournal of Palliative Medicine · 2023-08-16Psilocybin's Emerging Role in Combating Depressive DisorderJournal of Education Health and Sport · 2023-08-07A proof-of concept randomized controlled trial to show that the antidepressant effect of psilocybin does not require a psychedelic experience: study protocolUnknown journal · 2023-07-18A systematic review to assess the use of psilocybin in the treatment of headachesUnknown journal · 2023-07-18Systematic Review on the Mechanisms of Action of Psilocybin in the Treatment of DepressionUnknown journal · 2023-07-18Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trialBJPsych Open · 2023-06-30Psilocybin's Potential Mechanisms in the Treatment of Depression: A Systematic Review.Unknown journal · 2023-06-28Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant useJournal of Psychopharmacology · 2023-06-07ID: 212703 Augmenting rTMS With Psilocybin-Assisted Psychotherapy (PAP) for PTSD: A Proof-of-Concept Study DesignNeuromodulation Technology at the Neural Interface · 2023-05-31The Effect of Combined Treatment of Psilocybin and Eugenol on Lipopolysaccharide-Induced Brain Inflammation in MiceMolecules · 2023-03-13Psilocybin rescues depressive phenotype and modulates serotonin-2A and glucocorticoid receptor mRNA expression in brain cortex of a stress animal modelNeuroscience Applied · 2022-12-31Subacute effects of a single dose of psilocybin on biomarkers of inflammation in healthy humans: An open-label preliminary investigationComprehensive Psychoneuroendocrinology · 2022-12-05Psilocybin mitigates the cognitive deficits observed in a rat model of Fragile X syndromePsychopharmacology · 2022-12-04A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression.Psychedelic Medicine · 2022-10-27A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap.Unknown journal · 2022-10-02Effects of classic psychedelic drugs on turbulent signatures in brain dynamics.Network Neuroscience · 2022-09-30Serotonin 5-HT2A, 5-HT2c and 5-HT1A receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response.Biomedicine & Pharmacotherapy · 2022-08-29Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dying.PLoS ONE · 2022-08-23Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness.Journal of palliative medicine · 2022-07-31Author Correction: Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls.Unknown journal · 2022-07-27Evaluation of Psilocybin in Anorexia Nervosa: Safety and EfficacyClinicalTrials.gov · 2022-07-24Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controlsVIUspace · 2022-06-29Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls.Scientific Reports · 2022-06-29Self-Reported Efficacy of Treatments in Cluster Headache: a Systematic Review of Survey Studies.Unknown journal · 2022-06-26Psilocybin-Mediated Attenuation of Gamma Band Auditory Steady-State Responses (ASSR) Is Driven by the Intensity of Cognitive and Emotional Domains of Psychedelic Experience.Journal of Personalized Medicine · 2022-06-18Natural language signatures of psilocybin microdosing.Psychopharmacology · 2022-06-08Can the revival of serotonergic psychedelic drugs as treatments for mental disorders help to characterize their risks and benefits?Expert opinion on drug safety · 2022-05-31P450. Pilot Study Evaluation of Psilocybin Therapy for Anorexia Nervosa: Safety, Acceptability, and Preliminary EfficacyBiological Psychiatry · 2022-04-27Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges.Expert Opinion on Drug Safety · 2022-04-26Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation.Unknown journal · 2022-04-26Production and extraction of psilocybin and psilocin from Psilocybe spp. mushroomsRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2022-04-05Evaluation of a quantitative analytical method for psilocin and psilocybin using HPLC-DADRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2022-04-05Natural language signatures of psilocybin microdosingbioRxiv · 2022-02-21The Therapeutic Potential of Psychedelic-assisted Therapies for Symptom Control in Patients Diagnosed With Serious Illness: A Systematic Review.Unknown journal · 2022-02-10In Silico Studies on Psilocybin Drug Derivatives Against SARS-CoV-2 and Cytokine Storm of Human Interleukin-6 Receptor.Frontiers in Immunology · 2022-01-13Neurochemical and behavioural characterisation of the psychedelic 5HT2AR agonist psilocybin in miceNeuroscience Applied · 2021-12-31Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?Frontiers in psychiatry · 2021-12-31P.0298 Evaluation of the acute mechanism of action of psilocybin in miceEuropean Neuropsychopharmacology · 2021-11-30Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial.BMJ Open · 2021-11-30Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers.Scientific Reports · 2021-11-17Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics.Unknown journal · 2021-09-23Use of alternative therapy with Psilocybin in oncologic patients with depression and/or anxiety disorders - integrative reviewResearch Society and Development · 2021-08-18Therapeutic interventions for PTSD - current evidence on the the role of psychedelicsUnknown journal · 2021-08-12Psychedelics and psychiatric disorders: A emerging roleUnknown journal · 2021-08-12Effects of psilocybin-assisted therapy on treatment-resistant depressionUnknown journal · 2021-08-12Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?Unknown journal · 2021-08-12Effects of Ayahuasca on Personality: Results of Two Randomized, Placebo-Controlled Trials in Healthy Volunteers.Frontiers in Psychiatry · 2021-08-05Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports.Pharmacopsychiatry · 2021-08-03Anti-Inflammatory Effects of Four Psilocybin-Containing Magic Mushroom Water Extracts in vitro on 15-Lipoxygenase Activity and on Lipopolysaccharide-Induced Cyclooxygenase-2 and Inflammatory Cytokines in Human U937 Macrophage CellsJournal of Inflammation Research · 2021-07-31Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study.Frontiers in Psychiatry · 2021-06-15A utilização terapêutica da psilocibina como coadjuvante no tratamento do transtorno depressivo maior: uma revisão narrativa de literatura / The therapeutic use of psilocybin as an adjunct in the treatment of major depressive disorder: a narrative literature reviewBrazilian Journal of Health Review · 2021-05-02Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers: A Pilot, Proof-of-Concept, Randomized Controlled Trial.Journal of Clinical Psychopharmacology · 2021-04-30Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?European Psychiatry · 2021-03-31Effects of psilocybin-assisted therapy on treatment-resistant depressionEuropean Psychiatry · 2021-03-31